To view this email as a web page, click here.
 
MEN’S HEALTH MONDAY
 
New online men’s health sites divide opinion
Novel sites catering to men have emerged, along with conflicting views about Internet-based care.
Learn more
ADVERTISEMENT
 
Race does not affect docetaxel/prednisone response
Race does not affect oncologic response to treatment with docetaxel (Taxotere)/prednisone in men with metastatic castrate-resistant prostate cancer, according to a recent study.
Get the data
 
SURVEY
 
Is DRE still a relevant tool in the management of prostate cancer?
MORE FROM UROLOGY TIMES
 
Shock wave therapy: ED cure or unproven treatment?
Low T could hasten time to post-RP biochemical recurrence
JOB OPPORTUNITIES
 
NY-WNY Urology Associates
VT-University of Vermont
VT-University of Vermont
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.